Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Spier

Showing results (21-30 of 23) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 23 results.
Cancer Immunology, Immunotherapy : CII|June 1, 1995
Generation of cytotoxic effector cells against human melanomaS P Leong, Y M Zhou, M E Granberry, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 17, 2001
Phase I/II study of the P-glycoprotein modulator PSC 833 in patients with acute myeloid leukemiaR Dorr, C Karanes, C Spier, et al.
Blood|June 5, 2001
The Burkitt-like lymphomas: a Southwest Oncology Group study delineating phenotypic, genotypic, and clinical featuresR M Braziel, D A Arber, M L Slovak, et al.
Pageof 3

Showing results (21-30 of 23) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 23 results.
Cancer Immunology, Immunotherapy : CII|June 1, 1995
Generation of cytotoxic effector cells against human melanomaS P Leong, Y M Zhou, M E Granberry, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 17, 2001
Phase I/II study of the P-glycoprotein modulator PSC 833 in patients with acute myeloid leukemiaR Dorr, C Karanes, C Spier, et al.
Blood|June 5, 2001
The Burkitt-like lymphomas: a Southwest Oncology Group study delineating phenotypic, genotypic, and clinical featuresR M Braziel, D A Arber, M L Slovak, et al.
Pageof 3